Position in JNJ
as of Jun 30, 2026
· filed Jul 17, 2026
Position Value
$1,783,377
-$389,205 QoQ
Shares Held
7,022
-21.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.99%
of 13F equity value
Holder Rank
#2,450
of 4,676 holders
Holding Since
Dec 2023
11 quarters on record
Voting authority
Sole 91%
Shared 0%
None 9%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026ARVEST INVESTMENTS, INC. holds $10,070,233 across 7 Drug Manufacturers - General names. JNJ ranks #2 (17.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MRK |
Merck & Co., Inc.
|
30,803 | $3,958,185 | |
| 2 | JNJ |
Johnson & Johnson
This page
|
7,022 | $1,783,377 | |
| 3 | ABBV |
AbbVie Inc.
|
6,201 | $1,560,419 | |
| 4 | LLY |
ELI LILLY & Co
|
918 | $1,101,076 | |
| 5 | PFE |
Pfizer Inc
|
31,383 | $755,702 | |
| 6 | NVS |
Novartis AG
|
3,314 | $519,370 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
6,805 | $392,104 |
All Filings in JNJ
Export CSV
11 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,783,377 | 7,022 | Shares | Sole | 2026-07-17 | |
| 2026-03-31 | $2,172,582 | 8,888 | Shares | Sole | 2026-04-14 | |
| 2025-12-31 | $2,354,884 | 11,379 | Shares | Sole | 2026-01-20 | |
| 2025-09-30 | $2,181,651 | 11,766 | Shares | Sole | 2025-10-14 | |
| 2025-06-30 | $1,821,391 | 11,924 | Shares | Sole | 2025-07-03 | |
| 2025-03-31 | $2,458,412 | 14,824 | Shares | Sole | 2025-04-15 | |
| 2024-12-31 | $2,213,698 | 15,307 | Shares | Sole | 2025-02-11 | |
| 2024-09-30 | $2,661,187 | 16,421 | Shares | Sole | 2024-11-04 | |
| 2024-06-30 | $3,053,428 | 20,891 | Shares | Sole | 2024-08-08 | |
| 2024-03-31 | $3,356,633 | 21,219 | Shares | Sole | 2024-04-19 | |
| 2023-12-31 | $4,211,447 | 26,869 | Shares | Sole | 2024-01-24 | |
| No filing history on record for this holder in this stock. | ||||||